Modular Medical, Inc.(MODD)

Medical - Devices · San Diego, CA

$2.48+0.18 (+7.83%)

Delayed quote: Oct 6, 2026, 10:39 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T14:42:50.377Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:42:50.377Z.

Quote observation: 2026-10-06T14:39:39.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -25,531,000
Quote market capitalization: 20,214,041
Total debt · period ending 2026-06-30: 278,000
Cash · period ending 2026-06-30: 3,920,000

FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MODD EBITDA Yield Metrics

EBITDA YIELD

N/A

MODD Competitors' EBITDA Yield

MODD

Modular Medical, Inc.

Current

Market Cap

$20.21M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ESLA

Estrella Immunopharma, Inc.

vs MODD

Market Cap

$19.96M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACTU

Actuate Therapeutics Inc

vs MODD

Market Cap

$19.86M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COSM

Cosmos Health Inc.

vs MODD

Market Cap

$18.54M

EBITDA Yield

N/A

TTM Avg

2.57%

3Y Avg

2.17%

5Y Avg

2.17%

NXTC

NextCure, Inc.

vs MODD

Market Cap

$18.82M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs MODD

Market Cap

$18.70M

EBITDA Yield

N/A

TTM Avg

4.87%

3Y Avg

4.87%

5Y Avg

4.87%

AYTU

Aytu BioPharma, Inc.

vs MODD

Market Cap

$22.43M

EBITDA Yield

N/A

TTM Avg

24.06%

3Y Avg

27.42%

5Y Avg

27.42%

LONA

LeonaBio, Inc.

vs MODD

Market Cap

$22.64M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LPCN

Lipocine Inc.

vs MODD

Market Cap

$17.15M

EBITDA Yield

N/A

TTM Avg

6.12%

3Y Avg

6.12%

5Y Avg

6.12%

MRKR

Marker Therapeutics, Inc.

vs MODD

Market Cap

$17.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Modular Medical, Inc. (MODD)	$20.21M	N/A	N/A	N/A	N/A
Estrella Immunopharma, Inc. (ESLA)vs ›	$19.96M	N/A	N/A	N/A	N/A
Actuate Therapeutics Inc (ACTU)vs ›	$19.86M	N/A	N/A	N/A	N/A
Cosmos Health Inc. (COSM)vs ›	$18.54M	N/A	2.57%	2.17%	2.17%
NextCure, Inc. (NXTC)vs ›	$18.82M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.70M	N/A	4.87%	4.87%	4.87%
Aytu BioPharma, Inc. (AYTU)vs ›	$22.43M	N/A	24.06%	27.42%	27.42%
LeonaBio, Inc. (LONA)vs ›	$22.64M	N/A	N/A	N/A	N/A
Lipocine Inc. (LPCN)vs ›	$17.15M	N/A	6.12%	6.12%	6.12%
Marker Therapeutics, Inc. (MRKR)vs ›	$17.09M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

MODD EBITDA Yield Metrics

MODD Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics